// company-profile

SAB Biotherapeutics, Inc.

SABS
ExchangeNasdaqSectorBiological Products, (No Diagnostic Substances)Inc.DEFilings57Insiders23
// api This SAB Biotherapeutics, Inc. insider-trading data is served live by the Form4API insider trading API. Get the same data via API.

// activity-summary

No insider transactions in the last 30 days.

No insider activity recorded for SABS in the last 90 days.

Institutional Ownership

Top 13F-HR holders of SAB Biotherapeutics, Inc. as of 2026-03-31

↑ increasing
Total reported AUM
$260.2M
QoQ change
+103.7%
Reporting period
2026-03-31
#1
Vivo Capital, LLC
CIK 1674712
$43.7M
11.4M shares
#2
Caligan Partners LP
CIK 1727492
$30.5M
8.0M shares
#3
PERCEPTIVE ADVISORS LLC
CIK 1224962
$24.6M
6.4M shares

Data source: SEC Form 13F-HR filings. Joined with insider activity above — see who's loading up institutionally while insiders are trading. Full 13F-HR API →

Insider Transactions

Sourced from SEC EDGAR Form 4 filings. Updated hourly.

DateInsiderCompanyTypeSharesPriceValue
Mar 24, 2026Kropotova AlexandraSABS
Tax Withholding
988
Feb 3, 2026Sullivan Eddie JoeSABS
Award
3,000,000$0.00$0K
Feb 3, 2026To LucySABS
Award
2,400,000$0.00$0K
Feb 3, 2026Reich Samuel JSABS
Award
4,800,000$0.00$0K
Feb 3, 2026Bausch Christoph LawrenceSABS
Award
1,800,000$0.00$0K

45 more transactions hidden

Free account · No credit card required

Building something? Get API access →

Popular companies on Form4API

Browse insider trading activity for other actively-filed companies.